Cardiac resynchronisation has proved even more beneficial in severe heart failure than was proven a year ago by early results from the CARE-HF study. At the European Cardiology meeting in Stockholm John Cleland of Hull has now presented the latest findings. He talked to Audio Medica.
[audio:https://www.audiomedica.com/podcasting/12.John_Cleland-Cardiac_resynchronisation_has_proved_even_more_beneficial_in_severe_heart_failure.mp3]
Optimized Anti-Platelet Therapy Avoids Stent Thrombosis With Drug Eluting Stents: HORIZON-AMI Trial Results 31 Mar, 2009 
SAVOR-TIMI 53 study: saxagliptin had better glucose control than placebo but no cardiovascular benefit 22 Sep, 2013 
Direct infusions of HDL to prevent re-infarction in patients with acute coronary syndromes 16 Nov, 2012 COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk 26 Mar, 2007 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014